Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by DonkeyOateyon Jul 27, 2010 2:14am
609 Views
Post# 17298902

RE: RE: RE: CLASS ACTION AGAINST th

RE: RE: RE: CLASS ACTION AGAINST thPuppy -  You can have these news releases delivered to your e-mail by visiting TH's website. That way you are not last to know.  This was delivered to mine four hours ago.

Cheers!

Theratechnologies receives a motion of authorization to institute a class action
 
Montréal, Canada – July 26, 2010 - Theratechnologies (TSX:TH) announced today that it has received from 121851 Canada Inc.,formerly a shareholder of the Company, a motion of authorization toinstitute a class action against the Company and certainof its executive officers. This motion was filed in the Superior Courtof Quebec, district of Montreal. This person intends to initiate a classaction to represent the class of persons who were shareholders at May21, 2010 and who sold their common shares ofthe Company on May 25 or 26, 2010. This person alleges thatTheratechnologies did not comply with its continuous disclosureobligations as a reporting issuer by failing to disclose a materialchange. Theratechnologies is of the view that the allegations containedin the motion are frivolous and entirely without merit and intends totake all appropriate actions to vigorously defend its position.
 
Bullboard Posts